IM Cannabis (XCNQ:IMCC) Accounts Payable & Accrued Expense : C$16.04 Mil (As of Mar. 2025)

View and export this data going back to 1980. Start your Free Trial

What is IM Cannabis Accounts Payable & Accrued Expense?

IM Cannabis's quarterly accounts payable & accrued expense declined from Sep. 2024 (C$24.23 Mil) to Dec. 2024 (C$15.18 Mil) but then increased from Dec. 2024 (C$15.18 Mil) to Mar. 2025 (C$16.04 Mil).

IM Cannabis's annual accounts payable & accrued expense declined from Dec. 2022 (C$22.66 Mil) to Dec. 2023 (C$15.75 Mil) and declined from Dec. 2023 (C$15.75 Mil) to Dec. 2024 (C$15.18 Mil).

IM Cannabis Accounts Payable & Accrued Expense Historical Data

The historical data trend for IM Cannabis's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IM Cannabis Accounts Payable & Accrued Expense Chart

IM Cannabis Annual Data

Trend

Apr14

Apr16

Apr17

Apr18

Apr19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.82

31.77

22.66

15.75

15.18

IM Cannabis Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															16.12	18.36	24.23	15.18	16.04

IM Cannabis Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

IM Cannabis Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » IM Cannabis Corp (XCNQ:IMCC) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

IMCC:USA

Address

Central District, Kibbutz Glil Yam, ISR, 4690500

Website

https://www.imcannabis.com

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

Executives

Oren Shuster	Director, Senior Officer
Marc Lustig	Director, Senior Officer
Karl Grywacheski	Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)
Rafael Gabay	10% Security Holder